1) DL-Naproxen
萘普生混旋体
3) Naproxen enantiomers
萘普生对映体
1.
OBJECTIVE To investigate the distribution behavior of naproxen enantiomers in the extraction system with D(L)-isobutyl tartrate in 1,2-dichloroethane organic phase and HP-β-CD in aqueous phase,and to evaluate the influence of kind and concentration of tartaric acid esters,concentration of HP-β-CD and pH on extraction performance were investigated.
结果羟丙基β-环糊精对S-萘普生对映体的识别能力大于对R-萘普生对映体的识别能力,而L-酒石酸异丁酯的识别能力刚好相反;在羟丙基β-环糊精和L-酒石酸异丁酯萃取体系中,萘普生外消旋体一次萃取分离后R和S对映体的分配系数(kR和kS)分别为8。
4) naproxen
[英][nə'prɔksin] [美][nə'prɑksən]
萘普生
1.
Evaluation of HP-β-CD as Solubilizing/Stabilizing Agent for Naproxen;
羟丙基-β-环糊精对萘普生的增溶及稳定作用
2.
Preparation Technology and Characterization of Naproxen Microspheres;
萘普生缓释微球制备工艺及性能研究
3.
Preparation and in vitro release of naproxen microcapsules;
萘普生缓释微囊的制备及其体外释药研究
5) naproxen sodium
萘普生钠
1.
Simultaneous determination of naproxen sodium and pseudoephedrine hydrochloride sustained-release tablets by HPLC;
HPLC法同时测定萘普生钠伪麻黄碱缓释片中两组分的含量
2.
Formulation screening and optimization of bilayer tablet with metoclopramide rapid release layer and naproxen sodium sustained release layer;
甲氧氯普胺速释层与萘普生钠缓释层双层片的处方筛选及优化
3.
Studies on the effects of metoclopramide on absorption of naproxen sodium in rats;
甲氧氯普胺对大鼠体内萘普生钠吸收的影响
6) (S)-(+)-naproxen
(S)-(+)-萘普生
补充资料：萘普生混旋体
分子式：暂无
分子量：暂无
CAS号：暂无
性质：暂无
制备方法：暂无
用途：医药萘普生中间体。
分子量：暂无
CAS号：暂无
性质：暂无
制备方法：暂无
用途：医药萘普生中间体。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条